Phase II study of neoadjuvant bevacizumab with weekday-on/weekday-off capecitabine and radiation for locally advanced rectal cancer
Latest Information Update: 17 Aug 2013
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- 17 Aug 2013 New trial record